Psychiatric medication management works best when every medicine has a clear purpose, a responsible prescriber, and a review plan that other clinicians can follow. In Switzerland, start by reconciling what you actually take with your psychiatrist, general practitioner, and dispensing pharmacy. Ask who will interpret monitoring results, renew prescriptions, and respond when a problem occurs between appointments. A current medication list is useful, but it does not by itself establish that these responsibilities are covered.
This matters particularly when hospital treatment, private consultations, addiction care, and primary care overlap. Patient Safety Switzerland identifies admission and discharge as important points for systematic medication reconciliation. The aim is to resolve unintended discrepancies, rather than assume that the newest printed list automatically explains every earlier change.
Start with the medicines actually being used
Bring prescription medicines, over-the-counter products, supplements, and any medicines obtained abroad into the same conversation. Include products taken only occasionally. State what you actually use and when, even if this differs from the written instruction. An accurate account helps the prescriber distinguish a medicine that has not helped from one that has been difficult to take consistently.
For each item, record the name, formulation, prescribed instructions, reason for treatment, and prescribing clinician. Add known allergies and previous troublesome reactions. If a name has changed after a pharmacy substitution or international move, ask the pharmacist to identify the active ingredient. Do not assume two differently named boxes contain different treatments, or that similar-looking names mean identical medicines.
The Swiss eMediplan initiative provides a standardized medication overview that can help patients and professionals see a complete list. Ask whether your practice or pharmacy can supply an updated plan. Whether the format is electronic or paper, check its date and who verified it. A neatly formatted document can still be outdated if a later hospital or specialist change has not been incorporated.
Separate a prescription renewal from a clinical review
A renewal keeps the supply going. A clinical review asks whether the treatment still fits your symptoms, health, preferences, and other medicines. Both can be necessary, but they answer different questions. If the appointment was booked only to issue a prescription, tell the practice in advance that you also need to discuss side effects or a change in mood.
NICE’s medicines optimization guidance describes medication review as a structured examination of a person’s medicines that involves the person and considers effectiveness, safety, and appropriateness. Its recommendations are clinical guidance rather than Swiss insurance rules. A useful practical application is to leave the review knowing why each medicine remains in the plan and what will be assessed next.
Prepare one or two concrete examples of benefit and burden. “I can now manage the morning commute, but I struggle to stay awake in afternoon meetings” tells the clinician more than “it is fine.” If the main concern is cost, swallowing, remembering doses, sexual function, or feeling emotionally different, say so directly. A concern does not need to be life-threatening to deserve attention.
Name the clinician responsible for each decision
When more than one clinician is involved, ask for explicit responsibility rather than relying on assumptions. A psychiatrist might advise on the psychiatric regimen while a general practitioner issues continuing prescriptions and arranges tests. Another arrangement may keep all prescribing with the specialist. What matters is that the professionals agree and that you know how the arrangement works.
| Task | What should be clear |
|---|---|
| Routine prescription | Which practice issues it, how much notice it requires, and who covers absence. |
| Medication change | Who authorizes the change and tells the other treating professionals. |
| Blood test or other monitoring | Who orders it, receives the result, interprets it, and contacts you. |
| New side effect | Which contact route to use and when urgent medical assessment is needed. |
| Transfer of care | Who remains responsible until the receiving clinician accepts the handoff. |
If clinicians offer different advice, ask them to reconcile it directly. Describe the disagreement precisely: the proposed change, who proposed it, and whether it has already been started. Avoid trying to create a compromise regimen yourself. Where the uncertainty concerns diagnosis or repeated unsuccessful treatment, a structured second opinion can help clarify the underlying question.
Monitoring depends on the medicine and the person
Psychiatric medicines do not share one universal test schedule. The National Institute of Mental Health explains that treatment response and side effects vary between individuals. Some medicines require physical measurements or laboratory monitoring as well as a conversation about symptoms. Ask which checks apply to your prescription, why they are needed, and what happens if a result falls outside the expected range.
Lithium illustrates why a clear plan matters. The NHS Specialist Pharmacy Service describes monitoring of lithium levels and kidney and thyroid function, with additional review when risks change. Use this to prompt discussion with your Swiss prescriber, not to copy a test schedule independently. Ask how the timing of a blood sample relates to your prescribed treatment and whom to contact if illness or another medicine changes the situation.
For an antipsychotic, ask how physical health effects will be followed alongside the psychiatric symptoms. For an antidepressant, ask when benefit, tolerability, and any worsening symptoms will be reviewed. The NIMH medication overview discusses metabolic monitoring with some antipsychotics and close attention to changes after starting antidepressants. These examples show why a generic “come back eventually” instruction needs a more specific follow-up arrangement.
Keep completed tests distinct from reviewed tests. If you have a blood sample taken at one location and see your psychiatrist elsewhere, confirm that the result reached the person expected to act on it. Ask what you should do if no one contacts you. Do not interpret silence as confirmation that every result was normal and every necessary review occurred.
Recognize changes that deserve earlier contact
Tell the prescribing team about new or worsening symptoms, a troublesome reaction, or a practical problem that is leading you to miss treatment. Explain when the issue began in relation to a medication change and whether anything else changed at the same time. A symptom that follows a new prescription may be related, but timing alone does not establish the cause.
Do not stop or alter psychiatric medication solely because an online account resembles your experience. The NIMH advises making changes with a healthcare professional. If you are considering stopping because the treatment feels unacceptable, say that clearly and request timely advice. The discussion should address your reason and a safe next step, rather than leave you choosing between silent continuation and an unplanned interruption.
Suspected adverse reactions can also be reported to Swissmedic through its patient reporting route. Proof that the medicine caused the event is not required to submit a suspicion. Reporting contributes to medicines surveillance; it does not replace assessment or treatment. If there is collapse, severe breathing difficulty, immediate danger, or another medical emergency, call Switzerland’s ambulance service on 144.
Include alcohol, substance use, and prescribed sedatives
A medication review is incomplete if the clinician knows only the pharmacy list. Give an honest account of alcohol, cannabis, nonprescribed substances, and sedatives obtained from other sources. Ask how these affect the interpretation of symptoms and the treatment plan. If substance use is difficult to discuss in a shared appointment, request a private conversation rather than leaving the information out.
People receiving opioid agonist treatment should make sure that their addiction prescriber is included when relevant medicines change. Our guide to opioid agonist treatment in Switzerland explains prescribing and dispensing handoffs. For regularly used benzodiazepines, the dependence guide explains why concerns about continued use and concerns about withdrawal need to be assessed together.
Share enough information, through an agreed route
Swiss confidentiality rules apply when health information is exchanged. The Federal Data Protection and Information Commissioner explains that professional secrecy also matters between clinicians; a colleague is not automatically entitled to every record simply because they are a healthcare professional. Discuss which information needs to go to the prescriber, pharmacy, laboratory, or receiving service, and how it will be sent securely.
You can ask to see and obtain your medical records under the FOPH’s patient access guidance. For medication coordination, request a concise explanation of the current regimen, important previous reactions, reasons for recent changes, and outstanding monitoring. A complete record may be useful, but a clearly identified current plan helps the receiving professional understand what applies now.
Before discharge or a move to another practice
Compare the discharge list with the medicines used before admission. Ask which were stopped, which were changed, which were newly started, and why. If a temporary medicine has an intended review or end point, make sure it is visible. Confirm the first follow-up appointment and the practical prescription arrangement through that date. This is especially valuable when discharge occurs shortly before a weekend or holiday.
At the next appointment, take the current list and describe any difference between the written plan and what happened at home. Ask the clinician to update the record and resolve remaining questions with the earlier team. Good coordination becomes concrete when you can identify the present regimen, the next review, the person responsible for results, and the route for help before that review.